ELKTON — Elkton Computers & More is a company dedicated to making most kinds of technology as good as new. Gerry Comer, 67, ...
Our opinions are our own. Here is a list of our partners and here's how we make money. A VA loan is a type of mortgage exclusively for military borrowers and their surviving spouses. These loans ...
Merck is bracing for the years of sales growth from oncology superstar Keytruda to take a sharp turn in 2028—and for more reasons than one. Along with a key U.S. patent expiring at the end of ...
ELKTON, Ore. — Traffic on the Elkton-Sutherlin Highway (OR-138) has been reduced to one lane following a crash six miles south of Elkton. Motorists are advised to watch for flaggers and workers ...
The VA said the individuals dismissed were “non-mission critical” probationary employees who have served less than two years, according to a department statement. The agency defined the non ...
*Estimated payments are calculated by Cars.com and are for informational purposes only. We’ve estimated your taxes based on your provided ZIP code. These estimates do not include title ...
"I'm here to tell you the truth," VA Secretary Doug Collins said. "We're not cutting healthcare, we're not cutting benefits." VA employees and elected officials say critical staff, including ...
In a call with journalists, the Illinois Democrat said her staff heard from VA employees who worked for the crisis line or supported the VA claims process. She said two from Illinois may have been ...
Merck (NYSE:MRK) and a plaintiff who is suing the drugmaker over allegations that the Gardasil HPV vaccine she received as a teen caused her heart issues and nerve pain have agreed to adjourn the ...
In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other cheap high dividend stocks. According to Deutsche Bank Wealth Management, the global ...
Gilead Sciences has defied analysts’ expectations by passing on its chance to license Arcus Biosciences’ potential rival to Merck & Co.’s kidney cancer drug Welireg. Gilead had the right to ...
Deutsche Bank analyst James Shin downgraded Merck (MRK) to Hold from Buy with a price target of $105, down from $128. The firm believes the “real culprit” for Merck shares remaining under ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results